Shoucheng Q3 Results: 30% Revenue Growth and HK$1B Buyback Plan Signal Confidence 
Pet-Food Revolution: Two New Global Surveys Reveal Growing Guardian Openness to Sustainable Diets for Dogs and Cats 
Eternal Group at Cosmoprof Asia 2025, The Fragrance Frontier: How Scent is Revolutionizing Spatial Design and the Olfactory Economy 
Viasat Confirms Successful Launch of ViaSat-3 F2 CytomX Therapeutics to Present at Upcoming Investor Conferences
SOUTH SAN FRANCISCO, Calif., Nov. 11, 2020 (GLOBE NEWSWIRE) — CytomX Therapeutics, Inc. (Nasdaq: CTMX),…
Ascendis Pharma A/S Reports Third Quarter 2020 Financial Results
– European Medicines Agency (EMA) validated the Marketing Authorisation Application (MAA) for TransConTM hGH (lonapegsomatropin) in…
Spectral Announces Third Quarter Results
Corporate Highlights: Dialco’s DIMI receives FDA 510(k) clearance for use in hospital and clinical settings…
Chalice Farms to Honor Veterans Day with Increased Military Discount
PORTLAND, Ore., Nov. 11, 2020 (GLOBE NEWSWIRE) — Golden Leaf Holdings Ltd. (CSE:GLH) (OTCQB:GLDFF) (“Golden…
Telo Genomics Announces the Final Assignment of Patents on Hematological Cancers, Liquid Biopsy and Alzheimer’s Disease
TORONTO, Nov. 11, 2020 (GLOBE NEWSWIRE) — Telo Genomics Corp. (TSX-V: TELO) (the “Company” or…
Teligent, Inc. Announces Adjournment of Special Meeting of Stockholders
Scheduled to Reconvene on November 25, 2020Company Urgently Encourages Stockholders to Vote BUENA, N.J., Nov….
J. Knipper and Company, Inc. Finalizes Acquisition of Eagle Pharmacy to Expand Company’s Pharmacy Programs, Scale and Automation Capabilities
One of the Largest Suppliers of Pharmaceutical Marketing Solutions and Specialty Pharmacy Services in the…
Shattuck Labs Announces Preclinical Proof of Concept Study on Gamma Delta T Cell Engager, GADLEN™, Platform at SITC 2020
AUSTIN, TX and DURHAM, NC, Nov. 11, 2020 (GLOBE NEWSWIRE) — Shattuck Labs, Inc. (Shattuck)…
Revive Therapeutics Provides Update on Oral Thin Film Product with Psilocybin
TORONTO, Nov. 11, 2020 (GLOBE NEWSWIRE) — Revive Therapeutics Ltd. (“Revive” or the “Company”) (CSE:…
Virtual KOL Roundtable Recap: Outlook Therapeutics and Firas Rahhal, MD, Discussed wet AMD Treatment Landscape and ONS-5010/LYTENAVA™
Dr. Rahhal, a leading retinal clinician, offered insight on wet AMD treatment and the potential…
Mersana Therapeutics Reports Preclinical Data from Immunosynthen STING-Agonist ADC Platform and Pipeline
Immunosynthen ADCs activate the STING pathway in both tumor-resident immune cells and in the tumor…
Sorrento Announces IND Filing for COVI-DROPS, an Intranasal Formulation of a High Potency Neutralizing Antibody Against SARS-CoV-2
IND filing today for STI-2099 (COVI-DROPS™) for a phase 1 safety and pharmacokinetic study in…
SOTIO Presents Interim Data from its Phase 1/1b Study of SO-C101 in Patients with Advanced Solid Tumors at SITC 2020
Late breaking poster demonstrates SO-C101 was well tolerated to date with no dose-limiting toxicities Confirmed…
Bellerophon to Present at the H.C. Wainwright 6th Annual Israel Conference
WARREN, N.J., Nov. 11, 2020 (GLOBE NEWSWIRE) — Bellerophon Therapeutics, Inc. (Nasdaq: BLPH) (“Bellerophon” or…
BioDelivery Sciences to Present Virtually and Host 1×1 Investor Meetings at the Annual Southwest IDEAS Investor Conference on November 18
RALEIGH, N.C., Nov. 11, 2020 (GLOBE NEWSWIRE) — BioDelivery Sciences International, Inc. (NASDAQ: BDSI), a…
Better Choice Company to Host Third Quarter 2020 Financial Results Call on November 18 at 8:30 a.m. ET
NEW YORK, Nov. 11, 2020 (GLOBE NEWSWIRE) — Better Choice Company (OTCQB: BTTR) (“Better Choice”),…
New Therapeutic Protocols Targeting Debilitating Disorders on the Horizon
NEW YORK, Nov. 11, 2020 (GLOBE NEWSWIRE) — via InvestorWire — Cybin Inc. (NEO: CYBN)…
Enlivex to Present Schedule for Sepsis, COVID-19 and Solid Cancer Programs at H.C. Wainwright’s 6th Annual Israel Conference
Nes Ziona, Israel, Nov. 11, 2020 (GLOBE NEWSWIRE) — Enlivex Therapeutics Ltd. (Nasdaq: ENLV, the…
Neoleukin Therapeutics to Present at the Stifel 2020 Virtual Healthcare Conference
SEATTLE, Nov. 11, 2020 (GLOBE NEWSWIRE) — Neoleukin Therapeutics, Inc., “Neoleukin” (NASDAQ:NLTX), a biopharmaceutical company…
Cue Biopharma to Present at Upcoming Investor Conferences in November 2020
CAMBRIDGE, Mass., Nov. 11, 2020 (GLOBE NEWSWIRE) — Cue Biopharma, Inc. (Nasdaq: CUE), a clinical-stage…